“…Abbreviations: PCL, poly(caprolactone); PLA, polylactic acid; GelMA, gelatin methacryloyl; PEGDA, poly(ethylene glycol) diacrylate; hMSCs, human mesenchymal stem cells; hAFSCs, human amniotic fluidderived stem cells; HA, hydroxyapatite; HUVECs, human umbilical vein endothelial cells; BMP, bone morphogenetic protein; VEGF, vascular endothelial growth factor; β-TCP, beta tricalcium phosphate, TGF, transforming growth factor, RGD, Arg-Gly-Asp [Colour figure can be viewed at wileyonlinelibrary.com] those aspects (Bose, Vahabzadeh, & Bandyopadhyay, 2013;Jariwala et al, 2015;Li, Chen, Fan, & Zhou, 2016;Wen et al, 2017). A major limitation is that such ceramic-based scaffolds (some of which have been listed in Figure 1) require post-fabrication processing such as high temperature sintering or dissolution in organic solvents (Almela et al, 2017;Roohani-Esfahani, Newman, & Zreiqat, 2016) to confer stability on constructs and hence do not support live-cell printing.…”